Literature DB >> 34957356

The Utility and Potential of Mathematical Models in Predicting Fibrinolytic Outcomes.

Brittany E Bannish1,2, Nathan E Hudson3.   

Abstract

The enzymatic degradation of blood clots, fibrinolysis, is an important part of a healthy hemostatic system. If intrinsic fibrinolysis is ineffective, thrombolysis - the clinically-induced enzymatic degradation of blood clots - may be necessary to treat life-threatening conditions. In this review we discuss recent models of fibrinolysis and thrombolysis, and open questions that could be resolved through modeling and modeling-experimental collaboration. In particular, we focus on 2- and 3-dimensional models that can be used to study effects of fibrin network structure and realistic blood vessel geometries on the phenomena underlying lytic outcomes. Significant open questions such as the role of clot contraction, network and inherent fiber tension, and fibrinolytic inhibitors in lysis could benefit from mathematical models aimed at understanding the underlying biological mechanisms.

Entities:  

Keywords:  clot contraction; fiber tension; fibrinolysis; inhibitors; mathematical model; thrombolysis

Year:  2021        PMID: 34957356      PMCID: PMC8694003          DOI: 10.1016/j.cobme.2021.100337

Source DB:  PubMed          Journal:  Curr Opin Biomed Eng        ISSN: 2468-4511


  63 in total

Review 1.  Basic mechanisms and regulation of fibrinolysis.

Authors:  C Longstaff; K Kolev
Journal:  J Thromb Haemost       Date:  2015-06       Impact factor: 5.824

2.  A structural and dynamic investigation of the facilitating effect of glycoprotein IIb/IIIa inhibitors in dissolving platelet-rich clots.

Authors:  J Ph Collet; G Montalescot; C Lesty; J W Weisel
Journal:  Circ Res       Date:  2002-03-08       Impact factor: 17.367

3.  TAFIa, PAI-1 and alpha-antiplasmin: complementary roles in regulating lysis of thrombi and plasma clots.

Authors:  N J Mutch; L Thomas; N R Moore; K M Lisiak; N A Booth
Journal:  J Thromb Haemost       Date:  2007-02-02       Impact factor: 5.824

4.  Plasminogen associates with phosphatidylserine-exposing platelets and contributes to thrombus lysis under flow.

Authors:  Claire S Whyte; Frauke Swieringa; Tom G Mastenbroek; Ausra S Lionikiene; Marcus D Lancé; Paola E J van der Meijden; Johan W M Heemskerk; Nicola J Mutch
Journal:  Blood       Date:  2015-02-23       Impact factor: 22.113

5.  On the specific interaction between the lysine-binding sites in plasmin and complementary sites in alpha2-antiplasmin and in fibrinogen.

Authors:  B Wiman; H R Lijnen; D Collen
Journal:  Biochim Biophys Acta       Date:  1979-07-25

6.  Thrombus lysis by uPA, scuPA and tPA is regulated by plasma TAFI.

Authors:  N J Mutch; N R Moore; E Wang; N A Booth
Journal:  J Thromb Haemost       Date:  2003-09       Impact factor: 5.824

7.  Co-ordinated spatial propagation of blood plasma clotting and fibrinolytic fronts.

Authors:  Ansar S Zhalyalov; Mikhail A Panteleev; Marina A Gracheva; Fazoil I Ataullakhanov; Alexey M Shibeko
Journal:  PLoS One       Date:  2017-07-07       Impact factor: 3.240

Review 8.  Biophysical Mechanisms Mediating Fibrin Fiber Lysis.

Authors:  Nathan E Hudson
Journal:  Biomed Res Int       Date:  2017-05-28       Impact factor: 3.411

9.  Faster fibrin clot degradation characterizes patients with central pulmonary embolism at a low risk of recurrent peripheral embolism.

Authors:  Robert W Kupis; Sarah Goldman-Mazur; Maciej Polak; Michał Ząbczyk; Anetta Undas
Journal:  Sci Rep       Date:  2019-01-11       Impact factor: 4.379

10.  Computational Simulations of Thrombolytic Therapy in Acute Ischaemic Stroke.

Authors:  Andris Piebalgs; Boram Gu; Dylan Roi; Kyriakos Lobotesis; Simon Thom; Xiao Yun Xu
Journal:  Sci Rep       Date:  2018-10-25       Impact factor: 4.379

View more
  1 in total

1.  Microscale structural changes of individual fibrin fibers during fibrinolysis.

Authors:  Spencer R Lynch; Sean M Laverty; Brittany E Bannish; Nathan E Hudson
Journal:  Acta Biomater       Date:  2022-01-07       Impact factor: 8.947

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.